Protection against Schistosoma mansoni infection with a recombinant baculovirus-expressed subunit of calpain (Q39078061)

8 September 2017

Protection against Schistosoma mansoni infection with a recombinant baculovirus-expressed subunit of calpain (English)

1 reference

8 September 2017

0 references

Hota-Mitchell S

1

1 reference

8 September 2017

Siddiqui AA

2

1 reference

8 September 2017

Dekaban GA

3

1 reference

8 September 2017

Smith J

4

1 reference

8 September 2017

Tognon C

5

1 reference

8 September 2017

Podesta RB

6

1 reference

8 September 2017

language of work or name

English

0 references

publication date

1 October 1997

1 reference

8 September 2017

10

1 reference

inferred from page(s)

published in

Vaccine

1 reference

8 September 2017

15

1 reference

8 September 2017

15

1 reference

8 September 2017

1631-1640

1 reference

The pathogenesis of granulomatous inflammation and organ injury in schistosomiasis: interactions between the schistosome ova and the host

8 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Schistosomiasis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Schistosome resistance to praziquantel: Fact or artifact?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Praziquantel: an urgent and exciting challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Morbidity, due to schistosomiasis mansoni, and its control in Subsaharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

1 reference

7 January 2021

Prospects for immunological control of schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Molecular basis of host-parasite relationship: towards the definition of protective antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

'Concealed' antigens: expanding the range of immunological targets

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

The functional and immunological significance of some schistosome surface molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Protective immunization of mice against Schistosoma mansoni with purified adult worm surface membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Antigenicity of adult Schistosoma mansoni alkaline phosphatase

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Schistosoma mansoni: characterization and identification of calcium-binding proteins associated with the apical plasma membrane and envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Characterization of Ca(2+)-dependent neutral protease (calpain) from human blood flukes, Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Molecular cloning and sequence analysis of a calcium-activated neutral protease (calpain) from Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Expression and immunogenicity of the entire human T cell leukaemia virus type I envelope protein produced in a baculovirus system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Biochemical properties of a 24 kilodalton membrane glycoprotein antigen complex from Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Comparative analysis of the antibody response to the HTLV-I gag and env proteins in HTLV-I asymptomatic carriers and HAM/TSP patients: an isotype and subclass analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Immunological adjuvants: Desirable properties and side-effects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Calcium-activated neutral protease (calpain) system: structure, function, and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Calpain: new perspectives in molecular diversity and physiological-pathological involvement.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Human immunity to Schistosoma mansoni: observations on mechanisms, and implications for control

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

High-affinity IgE receptor on eosinophils is involved in defence against parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Immunity to helminths: is too much IgE parasite--rather than host-protective?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

IgE antibody and resistance to infection. II. Effect of IgE suppression on the early and late skin reaction and resistance of rats to Schistosoma mansoni infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

The blocking of human antibody-dependent, eosinophil-mediated killing of Schistosoma mansoni schistosomula by monoclonal antibodies which cross-react with a polysaccharide-containing egg antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Adjuvants for anti-parasite vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

IL-12: initiation cytokine for cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Impaired balance of interleukin-4 and interferon-gamma production in infections with Schistosoma mansoni and intestinal nematodes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

Larvicidal properties of macrophages induced by cloned murine schistosomal egg antigen-specific CD4 positive T-helper lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900081-9

1 reference

7 January 2021

10.1016/S0264-410X(97)00081-9

Identifiers

DOI

1 reference

8 September 2017

1 reference